BACKGROUND Tajikistan, considered highly endemic area for hepatitis B virus (HBV) in a pre-vaccine era, introduced hepatitis B vaccine in 2002 and reported ≥80% coverage with three doses of hepatitis B vaccine (HepB3) since 2004. However, the impact of vaccine introduction has not been assessed. METHODS We tested residual serum specimens from a 2010 national serosurvey for vaccine-preventable...

normal 0 false false false en-us x-none ar-sa microsoftinternetexplorer4 normal 0 false false false en-us x-none ar-sa microsoftinternetexplorer4 aim : in this study we co-administered melittin along with hbsag/alum vaccine to investigate if it helps elicitation of th1/th2 response. background : hepatitis b virus (hbv) infection is a life-threatening liver infection, which can lead to chronic l...

Background: Hepatitis B virus (HBV) infection causes significant morbidity and mortality worldwide. Occupational exposure of health care workers and medical students increases their risk of acquiring HBV infection, and many authorities recommend vaccination. However, significant proportions of health care workers do not receive HBV immunization, and remain at increased risk to HBV infection. Ob...

Chronic hepatitis B (CHB), caused by persistent virus (HBV) infection, significantly increases the risk of leading to liver diseases. Despite successful development and implementation HBV prophylactic vaccines for several decades, therapeutic vaccine, a substantially potential strategy eradicate achieve CHB cure, remains great challenge. Herein, we applied flash nanocomplexation (FNC) technolog...

In 1999, on the occasion of the application of the first vaccine dose during the state vaccination campaign against hepatitis B virus (HBV), 390 individuals from the town of Rio Branco, Acre, aged two or more years were selected for the determination of the seroprevalence of HBV and HCV. HBV markers (HBsAg, anti-HBs, and anti-HBc IgG) were determined on this occasion and anti-HBs antibodies wer...

BACKGROUND Hepatitis B virus (HBV) infection is endemic in China; perinatal transmission is the main source of chronic HBV infection. Simultaneous administration of hepatitis B immune globulin (HBIG) and hepatitis B vaccine is highly effective to prevent perinatal transmission of HBV; however, the effectiveness also depends on full adherence to the recommended protocols in daily practice. In th...

background: due to their similar routes of transmission, human immunodeficiency virus (hiv) and hepatitis b virus (hbv) co-infection occurs considerably. hbv infection progresses more rapidly in hiv-infected patients. therefore, hbv vaccination of all non-immune hiv infected patients is recommended. on the other hand, hiv-infected subjects have suboptimal responses to hbv vaccine. in this study...

background & objectives: hepatitis b is one of the major health problems in the world. health care workers (hcws) are at high risk of acquiring hepatitis b virus. the aim of this study was to evaluate the prevalence of hbv infection and the immune response to hbv vaccine among the hcws in babol, northern iran. methods: this study was accomplished on 527 hcws and administrative staff working...

we developed an immunogen to stimulate multivalent immunity against hepatitis b surface antigen (hbsag) and hepatitis b core antigens (hbcag). immune responses specific for both hbsag and hbcag play an important role in controlling the infection. hbsag-specific antibodies mediate elimination of virions at an early stage of infection and prevent the spread of virus. the immunogen was constructed...